Creative Biolabs is your ideal partner to advance your immuno-oncology pipeline. We are dedicated to providing services to evaluate the effect of self-destruction cancer cells in vivo. Our specialized cancer treatment development services and support team offer assistance in choosing the best assays suitable for clients’ experimental goals.
Recently, engineered cancer cells are promising therapeutic methods that kill tumor cells themselves and stimulate the immune system to both destroy primary tumors and prevent cancer. Self-destruction cancer cells are genetically manipulated to express costimulatory molecules, cytokines, and chemokines. These cancer cells allow for a greater variety of antigens to be presented to the immune system. The rich choice of antigenic targets increases the likelihood of a successful immune response.
Fig.1 The engineered cancer cells are used in cancer therapy. (Yildizhan, et al., 2018)
The engineered tumor cells would make them easier for the immune system to target and remember, priming the immune system for a long-term anti-tumor response. We offer customizable study designs, to test the effectiveness of engineered cancer cells on the preexistent tumor to advance cancer research and enable the selection of immuno-therapeutics and personalized cancer treatments. Our team is an expert in mouse models of cancer and the evaluation of immune responses. We provide information about tumor growth, as well as molecular imaging of cell behavior in vivo, histological and immunohistochemical staining and analysis. We can help design appropriate studies, select the best model platform and customize assays to help you reach your goals.
In vivo efficacy and anti-tumor immune response assays we provide include:
If your desired service is not listed, please contact us.
Key advantages include but not limited to:
In vivo models are indispensable for the evaluation of the effect of cancer immunotherapies or cancer vaccines. Creative Biolabs is highly experienced with evaluating the efficacy of potential cancer therapeutics using xenograft and syngeneic mouse tumor models. We help our clients to develop cancer therapies that are efficient, cost-effective, and clinically relevant. We have supported a variety of basic research projects and pre-clinical research in cancer research and therapy development. Our scientists can design and perform experiments that produce accurate data. We will be pleased to send an immediate price quotation and project timeline estimate. Please get in touch to discuss a custom solution.
Reference
For Research Use Only | Not For Clinical Use
Download our brochure